Cognitive dysfunction in systemic lupus erythematosus: how do we advance our understanding?

Lancet Rheumatol

Centre for Inflammatory Diseases, School of Clinical Sciences, Monash University, Melbourne, VIC, Australia; Rheumatology Department, Monash Health, Melbourne, VIC, Australia.

Published: April 2022

Despite the high reported prevalence and burden of cognitive dysfunction in systemic lupus erythematosus (SLE), there is poor understanding of its aetiology, clinical assessment, and management. In part, this lack of understanding is due to conceptual disorganisation in the available literature. In this Review, we address key knowledge gaps in the nomenclature, assessment, and interpretation of cognitive dysfunction in SLE. We apply basic principles of neuropsychology and incorporate lessons from other disease states to recommend principles that can help researchers to design studies in SLE. Better understanding of the trajectory of cognitive dysfunction in SLE will help to inform therapeutic trials, including the appropriate selection of outcome measures to capture clinically meaningful responses.

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2665-9913(21)00331-3DOI Listing

Publication Analysis

Top Keywords

cognitive dysfunction
16
dysfunction systemic
8
systemic lupus
8
lupus erythematosus
8
dysfunction sle
8
cognitive
4
erythematosus advance
4
advance understanding?
4
understanding? despite
4
despite high
4

Similar Publications

Alzheimer's disease (AD) is the most prevalent neurodegenerative dementia, marked by progressive cognitive decline and memory impairment. Despite advances in therapeutic research, single-target-directed treatments often fall short in addressing the complex, multifactorial nature of AD. This arises from various pathological features, including amyloid-β (Aβ) aggregate deposition, metal ion dysregulation, oxidative stress, impaired neurotransmission, neuroinflammation, mitochondrial dysfunction, and neuronal cell death.

View Article and Find Full Text PDF

Neuropsychiatric symptoms and specific cognitive domains in mild cognitive impairment.

Dement Neuropsychol

January 2025

Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Departamento de Psiquiatria, Campinas SP, Brazil.

Unlabelled: Neuropsychiatric symptoms (NPS) such as depression, anxiety, and apathy are present in mild cognitive impairment (MCI) and are risk factors for cognitive decline. However, the relationship between NPS and specific cognitive domains is less clear.

Objective: This study aimed to assess whether there is a correlation between NPS and specific cognitive domains.

View Article and Find Full Text PDF

Elevated BACE1 and IFNγ+ T Cells in Patients with Cognitive Impairment and the 5xFAD Mouse Model.

ACS Chem Neurosci

January 2025

Department of International Medical, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Lujiang Road 373, Hefei 230001, Anhui, China.

The dysregulation of T cell differentiation was associated with cognitive impairment. Recently, the peripheric β-secretase (BACE1) has been suggested as a regulator of T cell differentiation, which was increased in both cognitive impairment (CI) and type 2 diabetes mellitus (T2DM) in CI patients. However, the relationship between T cell dysfunction and CI remains unclear.

View Article and Find Full Text PDF

Rationale: One of the most debilitating drawbacks of cisplatin chemotherapy is neurotoxicity which elicits memory impairment and cognitive dysfunction (chemobrain). This is primarily triggered by oxidative stress and inflammation. Captopril, an angiotensin-converting enzyme inhibitor, has been reported as a neuroprotective agent owing to its antioxidant and anti-inflammatory effects.

View Article and Find Full Text PDF

Background: Neurological dysfunction is a common complication of traumatic brain injury (TBI), and early treatments are critical for the long-term prognosis. This study aimed to investigate whether hypidone hydrochloride (YL-0919) improves neurological function impairment in mice with TBI.

Methods: TBI was induced in adult male C57BL/6J mice using the controlled cortical impact (CCI) method.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!